Testing effectiveness (Phase 2)Study completedNCT00017212What this trial is testingDX-8951f in Treating Patients With Metastatic Stomach CancerWho this might be right forEsophageal CancerGastric Cancer Daiichi Sankyo
Large-scale testing (Phase 3)WithdrawnNCT01646554What this trial is testingEfficacy of FOLFOX Versus FOLFOX Plus Aflibercept in K-ras Mutant Patients With Resectable Liver MetastasesWho this might be right forColorectal Cancer MetastaticLiver MetastasesKRAS Mutated Colorectal Cancer European Organisation for Research and Treatment of Cancer - EORTC
Testing effectiveness (Phase 2)Study completedNCT04547153What this trial is testingInfusional Fluorouracil and Weekly Docetaxel for Gastric Cancer With Bone Marrow Involvement and DICWho this might be right forGastric CancerBone Marrow MetastasisDisseminated Intravascular Coagulation Sixth Affiliated Hospital, Sun Yat-sen University 24
Not applicableStudy completedNCT00499395What this trial is testingFludeoxyglucose F 18-PET Imaging for Early Detection of Residual Disease in Patients Undergoing Radiofrequency Ablation of Liver Metastases From Colorectal CancerWho this might be right forColorectal CancerMetastatic Cancer UNC Lineberger Comprehensive Cancer Center 4
Testing effectiveness (Phase 2)UnknownNCT06078657What this trial is testingIBI110 Combined With Sintilimab in Second-line Advanced or Metastatic Esophageal Squamous Cell Carcinoma(ESCC)Who this might be right forEsophageal Squamous Cell Carcinoma (ESCC)PD-1 Inhibitors The First Affiliated Hospital of Zhengzhou University 46
Large-scale testing (Phase 3)Study completedNCT01955837What this trial is testingStudy of Trifluridine/Tipiracil (TAS-102) in Patients With Metastatic Colorectal Cancer in AsiaWho this might be right forColorectal Cancer Taiho Pharmaceutical Co., Ltd. 406
Not applicableStudy completedNCT01343901What this trial is testingAn Observational Study on Bevacizumab (Avastin) as First-Line Treatment in Colorectal Cancer Participants With Potentially Resectable Liver MetastasesWho this might be right forColorectal Cancer Hoffmann-La Roche 210
Early research (Phase 1)Ended earlyNCT04458259What this trial is testingStudy of PF-07265807 in Participants With Metastatic Solid Tumors.Who this might be right forNeoplasm Metastasis Pfizer 88
Testing effectiveness (Phase 2)Study completedNCT01525056What this trial is testingRectal Cancer: Local Staging, Re-staging and Assessment of Lymph Nodes Using Pet-Ct, CT-Perfusion and 3T MRIWho this might be right forRectal Cancer London Health Sciences Centre 30
Testing effectiveness (Phase 2)Study completedNCT03800602What this trial is testingNivolumab and Metformin in Patients With Treatment Refractory MSS Colorectal CancerWho this might be right forColorectal AdenocarcinomaMetastatic Microsatellite Stable Colorectal CarcinomaRefractory Colorectal Carcinoma+5 more Emory University 29
Not applicableStudy completedNCT02088775What this trial is testingPET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary CancerWho this might be right forAdult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerMetastatic Extrahepatic Bile Duct Cancer+4 more Fox Chase Cancer Center 44
Very early researchActive Not RecruitingNCT06011772What this trial is testingEGF-Depleting Therapy CIMAvax-EGF in Combination With Standard Therapy for RAS- and BRAF Wild-Type Metastatic Colorectal CancerWho this might be right forColo-rectal Cancer Roswell Park Cancer Institute 2
Not applicableStudy completedNCT02175095What this trial is testing[18F]FLT-PET as a Predictive Imaging Biomaker of Treatment Responses to RegorafenibWho this might be right forColorectal Cancer Asan Medical Center 68
Early research (Phase 1)Looking for participantsNCT05003895What this trial is testingGPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor MalignanciesWho this might be right forHepatocellular CarcinomaHepatocellular CancerMetastatic Hepatocellular Carcinoma National Cancer Institute (NCI) 38
Testing effectiveness (Phase 2)Study completedNCT01991873What this trial is testingMaintenance Therapy With 5-FU/FA Plus Panitumumab vs. 5-FU/FA Alone After Prior Induction and Re-induction After Progress for 1st-line Treatment of Metastatic Colorectal CancerWho this might be right forMetastatic Colorectal Cancer AIO-Studien-gGmbH 387
Testing effectiveness (Phase 2)UnknownNCT04718701What this trial is testingAnlotinib, Toripalimab and Nab-paclitaxel in Locally Advanced/Metastatic Pancreatic CancerWho this might be right forPancreatic NeoplasmMetastatic Pancreatic CancerLocally Advanced Pancreatic Adenocarcinoma The First Affiliated Hospital with Nanjing Medical University 53
Early research (Phase 1)Study completedNCT01576666What this trial is testingPhase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid TumorsWho this might be right forDose EscalationSafetyPreliminary Efficacy+9 more Novartis Pharmaceuticals 120
Early research (Phase 1)Ended earlyNCT06199466What this trial is testingA Trial of YL-13027 in Combination With Gemcitabine and Nab-paclitaxel in Patients With Refractory Metastatic Pancreatic CancerWho this might be right forMetastatic Pancreatic Cancer M.D. Anderson Cancer Center 4
Testing effectiveness (Phase 2)Ended earlyNCT03168594What this trial is testingStudy to Compare Irinotecan Combined With Cisplatin (IP) Versus Etoposide Combined With Cisplatin (EP) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine CarcinomaWho this might be right forNeuroendocrine Carcinoma Peking University 66
Early research (Phase 1)Study completedNCT00014456What this trial is testingCombination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid TumorsWho this might be right forBladder CancerBreast CancerCarcinoma of Unknown Primary+9 more Dartmouth-Hitchcock Medical Center 35